Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Tapper

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myelomaWilliam Tapper, Laura Chiecchio, Gian Paolo Dagrada, et al.
Nature Communications|November 22, 2017
Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young womenLatha Kadalayil, Sofia Khan, Heli Nevanlinna, et al.
Molecular Genetics & Genomic Medicine|June 2, 2015
Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer riskConor Smyth, Iva Špakulová, Owen Cotton-Barratt, et al.
Clinical Epigenetics|October 20, 2023
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cellsEleanor O'Brien, Carmen Tse, Ian Tracy, et al.
JCI Insight|April 28, 2026
Comparative analysis of distinct genomic landscapes in young-onset gBRCA1/2 breast cancerMwangala P Akamandisa, Mingyi Xia, Wilson Cheah, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
Nature Genetics|May 11, 2010
Genome-wide association study identifies five new breast cancer susceptibility lociClare Turnbull, Shahana Ahmed, Jonathan Morrison, et al.
Clinical Pharmacology and Therapeutics|January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma ConcentrationsChiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
BMC Proceedings|May 10, 2008
Genetic Analysis Workshop 15: gene expression analysis and approaches to detecting multiple functional lociHeather J Cordell, Mariza de Andrade, Marie-Claude Babron, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annals of Hematology|September 28, 2014
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genesJuliana Schwaab, Marcin Knut, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myelomaWilliam Tapper, Laura Chiecchio, Gian Paolo Dagrada, et al.
Nature Communications|November 22, 2017
Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young womenLatha Kadalayil, Sofia Khan, Heli Nevanlinna, et al.
Molecular Genetics & Genomic Medicine|June 2, 2015
Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer riskConor Smyth, Iva Špakulová, Owen Cotton-Barratt, et al.
Clinical Epigenetics|October 20, 2023
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cellsEleanor O'Brien, Carmen Tse, Ian Tracy, et al.
JCI Insight|April 28, 2026
Comparative analysis of distinct genomic landscapes in young-onset gBRCA1/2 breast cancerMwangala P Akamandisa, Mingyi Xia, Wilson Cheah, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
Nature Genetics|May 11, 2010
Genome-wide association study identifies five new breast cancer susceptibility lociClare Turnbull, Shahana Ahmed, Jonathan Morrison, et al.
Clinical Pharmacology and Therapeutics|January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma ConcentrationsChiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
BMC Proceedings|May 10, 2008
Genetic Analysis Workshop 15: gene expression analysis and approaches to detecting multiple functional lociHeather J Cordell, Mariza de Andrade, Marie-Claude Babron, et al.
Pageof 5